Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos
This study is currently recruiting participants.
Verified October 2012 by British Columbia Cancer Agency
Sponsor:
British Columbia Cancer Agency
Collaborator:
BC Cancer Foundation
Information provided by (Responsible Party):
British Columbia Cancer Agency
ClinicalTrials.gov Identifier:
NCT01719068
First received: October 30, 2012
Last updated: NA
Last verified: October 2012
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a pilot study that aims to develop a lung cancer screening program for workers in British Columbia, Canada exposed to asbestos who are at risk of developing lung cancer/pleural mesothelioma. This is high risk population is at of respiratory system diseases as a result of their occupational exposures. Additionally, knowledge garnered from this study will allow us to develop other studies that will further our understanding of asbestos related lung cancer and mesothelioma.
| Condition |
|---|
|
Mesothelioma Lung Cancer |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos |
Resource links provided by NLM:
Further study details as provided by British Columbia Cancer Agency:
Primary Outcome Measures:
- Development of Model to Predict Workers at highest risk of lung cancer/mesothelioma [ Time Frame: 3 years ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 200 |
| Study Start Date: | October 2012 |
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | October 2014 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| Workers exposed to asbestos |
Eligibility| Ages Eligible for Study: | 50 Years to 79 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
Workers in British Columbia who have been exposed to asbestos.
Criteria
Inclusion Criteria:
- Women or men age 50 to 79 years
history of exposure to asbestos at work and one or more of the following:
- lung cancer risk ≥2% over 3 years or
- asbestosis or pleural plaques on a chest x-ray or
- abnormal auto-antibodies level using the EarlyCDT test
- Capable of providing informed consent for screening procedures (low dose spiral CT, lung function, blood biomarkers).
Exclusion Criteria:
- Any medical condition, such as severe heart disease (e.g. unstable angina, chronic congestive heart failure), acute or chronic respiratory failure, or any disorder, that in the opinion of the physician unlikely to benefit from screening due to shortened life-expectancy from co-existing illnesses
- Have been previously diagnosed with mesothelioma
- Have had other cancer within the past 5 years with the exception of the following cancers: non-melanomatous skin cancer,localized prostate cancer, carcinoma in situ (CIS) of the cervix, or superficial bladder cancer. Treatment of the exceptions must have ended >6 months before registration into this study
- Pregnancy
- Unwilling to have a low dose CT scan of chest
- Unwilling to sign a consent
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01719068
Contacts
| Contact: Sharon Gee | 604-675-8089 | sgee@bccancer.bc.ca |
Locations
| Canada, British Columbia | |
| British Columbia Cancer Agency | Recruiting |
| Vancouver, British Columbia, Canada, V5Z1L3 | |
| Contact: Sharon Gee 604-675-8089 sgee@bccancer.bc.ca | |
| Principal Investigator: Stephen Lam, MD | |
| Sub-Investigator: Annette McWilliams, MD | |
| Sub-Investigator: Tawimas Shaipanich, MD | |
Sponsors and Collaborators
British Columbia Cancer Agency
BC Cancer Foundation
Investigators
| Principal Investigator: | Stephen Lam | British Columbia Cancer Agency |
More Information
No publications provided
| Responsible Party: | British Columbia Cancer Agency |
| ClinicalTrials.gov Identifier: | NCT01719068 History of Changes |
| Other Study ID Numbers: | H12-01812 |
| Study First Received: | October 30, 2012 |
| Last Updated: | October 30, 2012 |
| Health Authority: | Canada: Ethics Review Committee |
Keywords provided by British Columbia Cancer Agency:
|
Mesothelioma Lung Cancer Early Detection |
Additional relevant MeSH terms:
|
Lung Neoplasms Mesothelioma Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms by Site Neoplasms |
Lung Diseases Respiratory Tract Diseases Adenoma Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms, Mesothelial |
ClinicalTrials.gov processed this record on May 23, 2013